title: Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin.
abstract: The objective of the present study was to investigate the effect of melatonin on the liver inflammatory and regenerative response in an animal model of fulminant hepatic failure (FHF) of viral origin. Rabbits were experimentally infected with 2×10(4) hemagglutination units of a rabbit hemorrhagic disease virus (RHDV) isolate and received melatonin at two concentrations of 10 or 20mg/kg at 0, 12 and 24hr postinfection. RHDV infection induced an inflammatory response, with increased expression of toll-like receptor 4, high-mobility group box (HMGB)1, interleukin (IL)-1β, IL-6, tumor necrosis factor-α, and C-reactive protein, and decreased expression of decay accelerating factor (DAF/CD55). These effects were significantly reduced by melatonin. Matrix metalloproteinase-9 expression was also lowered in melatonin-treated rabbits. RHDV infection inhibited the hepatic regenerative/proliferative response, with a reduced expression of hepatocyte growth factor (HGF), epidermal growth factor, platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor and their receptors; these responses were prevented by melatonin administration. Melatonin treatment also resulted in reduced expression of phosphorylated Janus kinase and enhanced expression of extracellular mitogen-activated protein kinase (ERK) and signal transducer and activator of transcription (STAT) 3. Our findings show that anti-inflammatory effects and stimulation of regenerative mechanisms contribute to the beneficial effects of melatonin in rabbits with experimental infection by RHDV and support a potential hepatoprotective role of melatonin in FHF.
authors.affiliation: Institute of Biomedicine (IBIOMED), University of León, Spain.
authors.forename: Almudena
authors.initials: A
authors.lastname: Laliena
authors.forename: Beatriz
authors.initials: B
authors.lastname: San Miguel
authors.forename: Irene
authors.initials: I
authors.lastname: Crespo
authors.forename: Marcelino
authors.initials: M
authors.lastname: Alvarez
authors.forename: Javier
authors.initials: J
authors.lastname: González-Gallego
authors.forename: María J
authors.initials: MJ
authors.lastname: Tuñón
mesh_terms: D000818:Animals; D017250:Caliciviridae Infections / Q000188:drug therapy / Q000473:pathology; D024243:HMGB1 Protein / Q000096:biosynthesis; D017929:Hemorrhagic Disease Virus, Rabbit; D053583:Interleukin-1beta / Q000096:biosynthesis; D015850:Interleukin-6 / Q000096:biosynthesis; D017114:Liver Failure, Acute / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D008115:Liver Regeneration / Q000187:drug effects; D020780:Matrix Metalloproteinase 9 / Q000096:biosynthesis; D008550:Melatonin / Q000494:pharmacology / Q000627:therapeutic use*; D011817:Rabbits; D051197:Toll-Like Receptor 4 / Q000096:biosynthesis
chemical_list: D024243:HMGB1 Protein; D053583:Interleukin-1beta; D015850:Interleukin-6; D051197:Toll-Like Receptor 4; D020780:Matrix Metalloproteinase 9; D008550:Melatonin